Holen Sie sich die Stockscreener-App
5.91
3.90%
-0.24
Handel nachbörslich:
29.72
23.81
+402.88%
Finanzdaten der Relmada Therapeutics Inc-Aktie (RLMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
1.04%
10.33
|
10.22 | 18.22 | 19.08 | 23.01 |
| Operating Income/Loss |
1.04%
-10.33
|
-10.22 | -18.22 | -19.08 | -23.01 |
| Nonoperating Income/Loss |
33.54%
0.2359
|
0.3549 | 0.659 | 0.4184 | 1.2829 |
| Income/Loss From Continuing Operations Before Tax |
2.28%
-10.09
|
-9.8664 | -17.56 | -18.66 | -21.73 |
| Income/Loss From Continuing Operations After Tax |
2.28%
-10.09
|
-9.8664 | -17.56 | -18.66 | -21.73 |
|
Net Income/Loss
|
2.28%
-10.09
|
-9.8664 | -17.56 | -18.66 | -21.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
33.19
|
33.19 | 30.41 | 0.00351 | 30.17 |
| Diluted Average Shares |
0.00%
33.19
|
33.19 | 30.41 | 0.00351 | 30.17 |
| Basic Earnings Per Share |
0.00%
-0.30
|
-0.30 | -0.58 | -0.62 | -0.72 |
| Diluted Earnings Per Share |
0.00%
-0.30
|
-0.30 | -0.58 | -0.62 | -0.72 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):